LivaNova PLC - Ordinary Shares (LIVN): Price and Financial Metrics

LivaNova PLC - Ordinary Shares (LIVN): $50.77

2.40 (+4.96%)

POWR Rating

Component Grades














  • Growth is the dimension where LIVN ranks best; there it ranks ahead of 89.3% of US stocks.
  • The strongest trend for LIVN is in Growth, which has been heading up over the past 177 days.
  • LIVN's current lowest rank is in the Momentum metric (where it is better than 30.28% of US stocks).

LIVN Stock Summary

  • Price to trailing twelve month operating cash flow for LIVN is currently 37.02, higher than 88.56% of US stocks with positive operating cash flow.
  • With a year-over-year growth in debt of -29.45%, LIVANOVA PLC's debt growth rate surpasses merely 11.37% of about US stocks.
  • In terms of twelve month growth in earnings before interest and taxes, LIVANOVA PLC is reporting a growth rate of -105.36%; that's higher than just 14.87% of US stocks.
  • Stocks that are quantitatively similar to LIVN, based on their financial statements, market capitalization, and price volatility, are GNSS, CTS, BCOV, OLK, and APPN.
  • LIVN's SEC filings can be seen here. And to visit LIVANOVA PLC's official web site, go to

LIVN Valuation Summary

  • In comparison to the median Healthcare stock, LIVN's price/sales ratio is 36.84% higher, now standing at 2.6.
  • Over the past 84 months, LIVN's EV/EBIT ratio has gone up 100.3.

Below are key valuation metrics over time for LIVN.

Stock Date P/S P/B P/E EV/EBIT
LIVN 2022-09-23 2.6 2.1 -85.9 156.3
LIVN 2022-09-22 2.6 2.1 -84.2 153.4
LIVN 2022-09-21 2.7 2.1 -86.9 158.1
LIVN 2022-09-20 2.8 2.2 -90.5 164.5
LIVN 2022-09-19 2.8 2.2 -91.8 166.8
LIVN 2022-09-16 2.9 2.3 -93.9 170.4

LIVN Growth Metrics

    Its 2 year revenue growth rate is now at -4.45%.
  • The 3 year cash and equivalents growth rate now stands at 771.25%.
  • Its year over year revenue growth rate is now at 9.42%.
Over the past 52 months, LIVN's revenue has gone up $40,035,000.

The table below shows LIVN's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-06-30 1,017.605 73.013 -31.365
2022-03-31 1,027.937 108.887 -103.127
2021-12-31 1,035.365 102.544 -135.818
2021-09-30 1,034.856 106.049 -407.079
2021-06-30 1,021.724 90.753 -379.614
2021-03-31 939.447 46.103 -412.289

LIVN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • LIVN has a Quality Grade of C, ranking ahead of 45.21% of graded US stocks.
  • LIVN's asset turnover comes in at 0.441 -- ranking 110th of 186 Medical Equipment stocks.
  • XRAY, PDEX, and ZBH are the stocks whose asset turnover ratios are most correlated with LIVN.

The table below shows LIVN's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.441 0.662 -0.416
2021-06-30 0.421 0.653 -0.308
2021-03-31 0.383 0.654 -0.262
2020-12-31 0.378 0.662 -0.271
2020-09-30 0.385 0.683 -0.167
2020-06-30 0.397 0.690 -0.156

LIVN Price Target

For more insight on analysts targets of LIVN, see our LIVN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $100.71 Average Broker Recommendation 1.43 (Moderate Buy)

LIVN Stock Price Chart Interactive Chart >

Price chart for LIVN

LIVN Price/Volume Stats

Current price $50.77 52-week high $93.89
Prev. close $48.37 52-week low $47.09
Day low $48.46 Volume 629,800
Day high $52.90 Avg. volume 368,820
50-day MA $58.82 Dividend yield N/A
200-day MA $70.09 Market Cap 2.71B

LivaNova PLC - Ordinary Shares (LIVN) Company Bio

LivaNova PLC. offers cardiac surgery, cardiac rhythm management, and neuromodulation related products worldwide. The company was founded in 1987 and is based in London, England.

LIVN Latest News Stream

Event/Time News Detail
Loading, please wait...

LIVN Latest Social Stream

Loading social stream, please wait...

View Full LIVN Social Stream

Latest LIVN News From Around the Web

Below are the latest news stories about LIVANOVA PLC that investors may wish to consider to help them evaluate LIVN as an investment opportunity.

LivaNova to Announce Third-Quarter 2022 Results

LONDON, September 21, 2022--LivaNova PLC will host a conference call to discuss its third-quarter 2022 results on Wednesday, Nov. 2, 2022, at 12 p.m. London time (8 a.m. EDT).

Yahoo | September 21, 2022

LivaNova Board Appoints Brooke Story as a New Director

LONDON, September 15, 2022--LivaNova PLC today announced the LivaNova Board of Directors appointed Brooke Story to the Board, effective September 15, 2022.

Yahoo | September 15, 2022

LivaNova (LIVN) Gets a Buy Rating from Needham

Needham analyst Michael Matson reiterated a Buy rating on LivaNova (LIVN – Research Report) today and set a price target of $88.00. The company's shares closed last Wednesday at $62.99. According to, Matson is a 4-star analyst with an average return of 3.8% and a 48.2% success rate. Matson covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Cardiovascular Systems, and Zimmer Biomet Holdings. Currently, the analyst consensus on LivaNova is a Moderate Buy with an average price target of $93.50.

Christine Brown on TipRanks | August 3, 2022

LivaNova (LIVN) Q2 Earnings and Revenues Surpass Estimates

LivaNova (LIVN) delivered earnings and revenue surprises of 3.92% and 2.61%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | August 3, 2022

LivaNova Reports Second-Quarter 2022 Results

LONDON, August 03, 2022--LivaNova PLC, a market-leading medical technology and innovation company, today reported results for the quarter ended June 30, 2022.

Yahoo | August 3, 2022

Read More 'LIVN' Stories Here

LIVN Price Returns

1-mo -6.66%
3-mo N/A
6-mo -38.30%
1-year -37.44%
3-year -28.16%
5-year -30.04%
YTD -41.93%
2021 32.05%
2020 -12.22%
2019 -17.54%
2018 14.45%
2017 77.72%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.4659 seconds.